Focus: ProKidney is a pre-revenue biotechnology company focused on autologous kidney cell therapy, with a pipeline targeting diabetic kidney disease, chronic kidney disease, and type 2 diabetes. The company is based in Winston-Salem, NC and operates in the early-stage cell and gene therapy space.
Profile data last refreshed 14h ago · AI intelligence enriched 2w ago
Stable — net -2 jobs in 30d
6 added, 8 removed. Backfill posture.
ProKidney is a high-risk, early-stage cell therapy play suitable only for candidates comfortable with pre-revenue biotech volatility who seek hands-on manufacturing and process development roles.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for ProKidney
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from ProKidney's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles